LMG Life Sciences Awards EMEA 2023: key dates revealed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2023: key dates revealed

LMG-LS-2023-EMEA-logo-article

Key dates for the LMG Life Sciences research for 2023 have been released

The LMG Life Sciences Awards EMEA is excited to announce its return and reveal its key dates for 2023. The Awards, the preeminent industry event for legal work in the life sciences sector, will be open for submissions from December 8.

Please mark the following dates in your calendars:

LMG LS EMEA Dates.PNG

The life sciences industry will be invited to submit nominations for leading practitioners, firms, cases, and deals. The Awards will recognise the most outstanding work completed by private practice firms, as well as in-house legal teams and counsels during 2022.

If you have any questions about the research, please contact the LMG Life Sciences awards editor John Harrison.

 

LMG Life Sciences

LMG Life Sciences produces the most respected awards programme for life sciences practitioners and law firms across Europe, the Middle East, and Africa. Honourees are determined through a rigorous research process that aims to recognise and celebrate excellent legal work and client service over a 12-month period.

The awards span four broad practice areas: regulatory, intellectual property, financial & corporate, and non-IP litigation & enforcement.

In addition to award categories for firms and individuals, an array of unique awards are announced each year to highlight the achievements of in-house teams and to celebrate Impact Cases and Deals of the Year.

LMG Life Sciences is a sister publication to Managing IP and IP Stars.

more from across site and SHARED ros bottom lb

More from across our site

Increased focus on adding patent litigation depth to the firm’s Dallas office was behind the boutique’s most recent hires
IPH's Canadian acquisitions are paying off on paper, but a couple of strong years may not be enough to show that the group's strategy has truly won over the market
Examiner statistics could help patent prosecution practitioners tailor strategies, turning an area of high variability into a potential competitive advantage
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Firms with established sports relationships and specialised expertise are well positioned to capture the market’s expanded pool of IP work
Gunjan Paharia discusses developing RIA, an AI platform built to draw on decades of institutional knowledge, support junior lawyers, and reshape how legal teams work
A strong Canadian business helped lift profits, but the IP service group's latest results underline the pressure facing its operations in Australia, New Zealand and parts of Asia
Wins in court have been key to the six-year-old firm’s growth, as one of its founders explains
The firm’s co-CEO discusses patent litigation, collaboration with overseas colleagues and the next generation of leaders
Two recent decisions demonstrate the courts’ creativity in cutting-edge IP disputes that tested their jurisdictional powers
Gift this article